Christina M. Dollar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Christina M. Dollar has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Austin P. Gillies
Bone Health Program, Division of Orthopaedics & Sports Medicine, Children’s National Hospital, 111 Michigan Ave. NW, Washington, DC, 20010, USA
3 shared publications - Laura Lowe Tosi
Division of Orthopaedics & Sports Medicine, Children’s National Hospital , Washington, DC
3 shared publications - Marianne K. Floor
Artinis Medical Systems B.V., Elst, The Netherlands
3 shared publications - Tracy S. Hart
Osteogenesis Imperfecta Foundation, Gaithersburg, MD 20878, USA
3 shared publications - David Cuthbertson
Health Informatics Institute Morsani College of Medicine University of South Florida Tampa Florida USA
2 shared publications - Jeffrey P. Krischer
Health Informatics Institute, Morsani College of Medicine, University of South Florida, Tampa, USA
2 shared publications
Latest Publications
- 15 June 2023
- Published by Oxford University Press (OUP) in Archives of Clinical Neuropsychology
- Vol. 38 (5) , 826
A-24 Behavioral Regulation is Associated With De creased Post-Concussion State Anxiety and Depression
To examine the effects of self-reported behavioral regulation on post-concussion anxiety and depression in individuals with sport-related concussion (SRC) A retrospective chart review of patients (ages 15–25yrs) seeking care for a SRC within 1-7 days following injury were included in this study. Participants completed a self-report, 4-point Likert scale (0-Never, 3-Most of the Time) questionnaire that assessed the previous week’s frequency of Sleep, Physical Activity (PA), Diet, Hydration, and Stress Management behavioral regulation domains. Scores were divided into HIGH (Most of the Time) and LOW (Some of the Time – Never) regulation groups for each domain. A series of independent samples t-tests and analyses of covariance (ANCOVA) were used to compare these groups on state anxiety (STAI) and depression (PHQ-9) scores. One hundred thirty-two participants (M=16.42, SD=1.95 yrs, 45% female) completed the study measures at 3.85 days post injury (SD=1.40). Participants in the HIGH behavioral regulation groups for Sleep (F(1,129)=4.67, p=.03), PA (F(1,128)=8.88, p=.003), and Stress (t(130)=1.89, p=.03) demonstrated significantly lower state anxiety scores than the LOW groups. Depression scores were significantly lower for the HIGH behavioral regulation in Sleep (F(1,129)=8.70, p=.004), Diet (F(1,125)=10.22, p=.002), and PA (F(1,128)=5.09, p=.03) domains than the LOW groups. Behavioral regulation affects post-concussion state anxiety and depression. This low cost, non-pharmacological strategy should be the first step for the management of SRC.
- 15 June 2023
- Published by Oxford University Press (OUP) in Archives of Clinical Neuropsychology
- Vol. 38 (5) , 826
A-24 Behavioral Regulation is Associated With De creased Post-Concussion State Anxiety and Depression
To examine the effects of self-reported behavioral regulation on post-concussion anxiety and depression in individuals with sport-related concussion (SRC) A retrospective chart review of patients (ages 15–25yrs) seeking care for a SRC within 1-7 days following injury were included in this study. Participants completed a self-report, 4-point Likert scale (0-Never, 3-Most of the Time) questionnaire that assessed the previous week’s frequency of Sleep, Physical Activity (PA), Diet, Hydration, and Stress Management behavioral regulation domains. Scores were divided into HIGH (Most of the Time) and LOW (Some of the Time – Never) regulation groups for each domain. A series of independent samples t-tests and analyses of covariance (ANCOVA) were used to compare these groups on state anxiety (STAI) and depression (PHQ-9) scores. One hundred thirty-two participants (M=16.42, SD=1.95 yrs, 45% female) completed the study measures at 3.85 days post injury (SD=1.40). Participants in the HIGH behavioral regulation groups for Sleep (F(1,129)=4.67, p=.03), PA (F(1,128)=8.88, p=.003), and Stress (t(130)=1.89, p=.03) demonstrated significantly lower state anxiety scores than the LOW groups. Depression scores were significantly lower for the HIGH behavioral regulation in Sleep (F(1,129)=8.70, p=.004), Diet (F(1,125)=10.22, p=.002), and PA (F(1,128)=5.09, p=.03) domains than the LOW groups. Behavioral regulation affects post-concussion state anxiety and depression. This low cost, non-pharmacological strategy should be the first step for the management of SRC.
- 15 June 2023
- Published by Oxford University Press (OUP) in Archives of Clinical Neuropsychology
- Vol. 38 (5) , 858
A-56 Post-Concussion Depression Presents in Distinct and Unique Factors
Post-concussion depression is a commonly endorsed symptom, and a key component of both the Emotional Cluster of the Post-Concussion Symptom Scale and also the Anxiety/Mood Clinical Profile. The purpose of this study was to explore the overlap between the PCSS and items on a widely used measure of depression, the PHQ9, in concussed athletes. A sample of 365 athletes (mean age=15.10±2.25 years; 46% female) seeking care for a concussion at a specialty clinic within 30 days of injury (M= 7.79±7.1 days) were enrolled in the study. The PCSS and PHQ9 were administered to all participants. Two factor analyses were conducted, using: 1) all items from the PCSS and PHQ9, and 2) only the items from the PHQ9. The PCSS/PHQ9 FA identified only “Sadness” and “More Emotional” as sharing variance with PHQ9 items, including symptoms of “Feeling Down/Depressed/Hopeless”, “Feeling Bad About Self”, “Suicidal Thoughts” and “Little Interest/Pleasure in Doing Things”. PHQ9 items of “Trouble Concentrating”, “Moving/Speaking Slowly or Fidgety/Restless” and “Feeling Tired/Low Energy” loaded on a unique factor with no shared variance with PCSS items. Factor Analysis of only the PHQ9 items retained all but the “Poor Appetite or Overeating” item, yielding two distinct post-concussion depression factors: a Cognitive/Fatigue Factor and a Depressive/Rumination Factor. Post-concussion depression presents as a unique two-factor construct, with some shared variance with PCSS items. Use of an additional measure of depression is recommended to identify post-concussion depressive symptoms beyond “sadness” and “more emotional” and help clinicians determine an appropriate treatment plan.
- 15 June 2023
- Published by Oxford University Press (OUP) in Archives of Clinical Neuropsychology
- Vol. 38 (5) , 858
A-56 Post-Concussion Depression Presents in Distinct and Unique Factors
Post-concussion depression is a commonly endorsed symptom, and a key component of both the Emotional Cluster of the Post-Concussion Symptom Scale and also the Anxiety/Mood Clinical Profile. The purpose of this study was to explore the overlap between the PCSS and items on a widely used measure of depression, the PHQ9, in concussed athletes. A sample of 365 athletes (mean age=15.10±2.25 years; 46% female) seeking care for a concussion at a specialty clinic within 30 days of injury (M= 7.79±7.1 days) were enrolled in the study. The PCSS and PHQ9 were administered to all participants. Two factor analyses were conducted, using: 1) all items from the PCSS and PHQ9, and 2) only the items from the PHQ9. The PCSS/PHQ9 FA identified only “Sadness” and “More Emotional” as sharing variance with PHQ9 items, including symptoms of “Feeling Down/Depressed/Hopeless”, “Feeling Bad About Self”, “Suicidal Thoughts” and “Little Interest/Pleasure in Doing Things”. PHQ9 items of “Trouble Concentrating”, “Moving/Speaking Slowly or Fidgety/Restless” and “Feeling Tired/Low Energy” loaded on a unique factor with no shared variance with PCSS items. Factor Analysis of only the PHQ9 items retained all but the “Poor Appetite or Overeating” item, yielding two distinct post-concussion depression factors: a Cognitive/Fatigue Factor and a Depressive/Rumination Factor. Post-concussion depression presents as a unique two-factor construct, with some shared variance with PCSS items. Use of an additional measure of depression is recommended to identify post-concussion depressive symptoms beyond “sadness” and “more emotional” and help clinicians determine an appropriate treatment plan.
- Open Access
- 29 January 2019
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 14 (1) , 1-12
Assessing disease experience across the life span for individuals with osteogenesis imperfecta: challenges and opportunities for patient-reported outcomes (PROs) measurement: a pilot study
Patient reported outcome (PRO) information is crucial for establishing better patient-provider communication, improving shared decision-making between clinicians and patients, assessing patient responses to therapeutic interventions, and increasing satisfaction with care. We used the Brittle Bones Disease Consortium (BBDC) Contact Registry for People with OI, managed by the Rare Disease Clinical Research Network (RDCRN) to (1) to evaluate the construct validity of the Patient-Reported Outcome Measurement Information System® (PROMIS®) to record important components of the disease experience among individuals with OI; and (2) explore the feasibility of using a registry to recruit individuals with OI to report on health status. Our long-term goal is to enhance communication of health and disease management findings back to the OI community, especially those who do not have access to major OI clinical centers. We demonstrated the construct validity of PROMIS instruments in OI. Our results confirm that the scores from most domains differ significantly from the general US population: individuals with OI have worse symptom burden and functioning. We found no excessive floor or ceiling effects. Our study demonstrates that the BBDC Contact Registry can be used to recruit participants for online health status surveys. However, there are numerous challenges that must be addressed: lack of self-knowledge of OI type, under-representation of men, limited ethnic diversity, and imperfect questionnaire completion rates. Our pilot study demonstrated the feasibility of using a contact registry to recruit respondents from the OI community and to obtain analyzable PROMIS data regarding disease experience. Because the results differ from the general population and avoid excessive floor and ceiling effects, PROMIS instruments can be used to assess response to therapeutic interventions in individuals with OI. Future directions will include (1) development and validation of an OI-specific patient-based classification system that aggregates persons with similar clinical characteristics and risks for complications to identify treatment needs; and (2) integrating these PRO tools into routine patient care and research studies.
- 29 January 2019
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 14 (1) , 1-12
Open AccessAssessing disease experience across the life span for individuals with osteogenesis imperfecta: challenges and opportunities for patient-reported outcomes (PROs) measurement: a pilot study
Patient reported outcome (PRO) information is crucial for establishing better patient-provider communication, improving shared decision-making between clinicians and patients, assessing patient responses to therapeutic interventions, and increasing satisfaction with care. We used the Brittle Bones Disease Consortium (BBDC) Contact Registry for People with OI, managed by the Rare Disease Clinical Research Network (RDCRN) to (1) to evaluate the construct validity of the Patient-Reported Outcome Measurement Information System® (PROMIS®) to record important components of the disease experience among individuals with OI; and (2) explore the feasibility of using a registry to recruit individuals with OI to report on health status. Our long-term goal is to enhance communication of health and disease management findings back to the OI community, especially those who do not have access to major OI clinical centers. We demonstrated the construct validity of PROMIS instruments in OI. Our results confirm that the scores from most domains differ significantly from the general US population: individuals with OI have worse symptom burden and functioning. We found no excessive floor or ceiling effects. Our study demonstrates that the BBDC Contact Registry can be used to recruit participants for online health status surveys. However, there are numerous challenges that must be addressed: lack of self-knowledge of OI type, under-representation of men, limited ethnic diversity, and imperfect questionnaire completion rates. Our pilot study demonstrated the feasibility of using a contact registry to recruit respondents from the OI community and to obtain analyzable PROMIS data regarding disease experience. Because the results differ from the general population and avoid excessive floor and ceiling effects, PROMIS instruments can be used to assess response to therapeutic interventions in individuals with OI. Future directions will include (1) development and validation of an OI-specific patient-based classification system that aggregates persons with similar clinical characteristics and risks for complications to identify treatment needs; and (2) integrating these PRO tools into routine patient care and research studies.
- Open Access
Assessing Disease Experience across the Life Span for Individuals with Osteogenesis Imperfecta: Challenges and Opportunities for Patient-Reported Outcomes (PROs) Measurement
Background: Patient reported outcome (PRO) information is crucial for establishing better patient-provider communication, improving shared decision making between clinicians and patients, and assessing patient responses to therapeutic interventions and increasing satisfaction with care. We used the Brittle Bones Disease Consortium (BBDC) Contact Registry for People with OI, managed by the Rare Disease Clinical Research Network (RDCRN) to (1) to evaluate the construct validity of the Patient-Reported Outcome Measurement Information System ® (PROMIS ® ) to record important components of the disease experience among individuals with OI; and (2) explore the feasibility of using a registry to recruit individuals with OI to report on health status. Our long-term goal is to enhance communication of health and disease management findings back to the OI community, especially those who do not have access to major OI clinical centers. Results: We demonstrated the construct validity of PROMIS instruments in OI. Our results confirm that the scores from most domains differ significantly from the general US population: individuals with OI have worse symptom burden and functioning. We found no excessive floor or ceiling effects. Our study demonstrates that the BBDC Contact Registry can be used to recruit participants for online health status surveys. However, there are numerous challenges that must be addressed: lack of self-knowledge of OI type, under-representation of men, limited ethnic diversity, and imperfect questionnaire completion rates. Conclusion: Our pilot study demonstrated the feasibility of using a contact registry to recruit respondents from the OI community and to obtain analyzable PROMIS data regarding disease experience. Because the results differ from the general population and avoid excessive floor and ceiling effects, PROMIS instruments can be used to assess response to therapeutic interventions in individuals with OI. Future directions will include (1) development and validation of an OI-specific patient-based classification system that aggregates persons with similar clinical characteristics and risks for complications to identify treatment needs; and (2) integrating these PRO tools into routine patient care and research studies.
Open AccessAssessing Disease Experience across the Life Span for Individuals with Osteogenesis Imperfecta: Challenges and Opportunities for Patient-Reported Outcomes (PROs) Measurement
Background: Patient reported outcome (PRO) information is crucial for establishing better patient-provider communication, improving shared decision making between clinicians and patients, and assessing patient responses to therapeutic interventions and increasing satisfaction with care. We used the Brittle Bones Disease Consortium (BBDC) Contact Registry for People with OI, managed by the Rare Disease Clinical Research Network (RDCRN) to (1) to evaluate the construct validity of the Patient-Reported Outcome Measurement Information System ® (PROMIS ® ) to record important components of the disease experience among individuals with OI; and (2) explore the feasibility of using a registry to recruit individuals with OI to report on health status. Our long-term goal is to enhance communication of health and disease management findings back to the OI community, especially those who do not have access to major OI clinical centers. Results: We demonstrated the construct validity of PROMIS instruments in OI. Our results confirm that the scores from most domains differ significantly from the general US population: individuals with OI have worse symptom burden and functioning. We found no excessive floor or ceiling effects. Our study demonstrates that the BBDC Contact Registry can be used to recruit participants for online health status surveys. However, there are numerous challenges that must be addressed: lack of self-knowledge of OI type, under-representation of men, limited ethnic diversity, and imperfect questionnaire completion rates. Conclusion: Our pilot study demonstrated the feasibility of using a contact registry to recruit respondents from the OI community and to obtain analyzable PROMIS data regarding disease experience. Because the results differ from the general population and avoid excessive floor and ceiling effects, PROMIS instruments can be used to assess response to therapeutic interventions in individuals with OI. Future directions will include (1) development and validation of an OI-specific patient-based classification system that aggregates persons with similar clinical characteristics and risks for complications to identify treatment needs; and (2) integrating these PRO tools into routine patient care and research studies.
- Open Access
- 6 September 2018
- Published by Springer Nature in Osteoporosis International
- Vol. 30 (2) , 507-511
Incorporating the patient perspective in the study of rare bone disease: insights from the osteogenesis imperfecta community
Summary There is limited research which examines health concerns of individuals with osteogenesis imperfecta (OI). Discussion groups with leaders of the adult OI community identified a broad range of medical priorities beyond fractures and brittle bones. Our work underscores the need to include patient-reported outcomes in rare bone disease research. Introduction Osteogenesis imperfecta (OI) is a rare genetic disorder affecting collagen protein leading to brittle bones and a number of other medical complications. To date, there is limited research which examines the life-long process of aging with this rare disease, much less the perspective of individuals with OI. Methods In order to explore and prioritize health concerns that adults with OI feel have been inadequately addressed in health care and research, investigators held discussions with leaders from the global adult OI community. The meetings were held in August 2017 at the 13th International Conference on OI in Oslo, Norway as part of the preconference seminar “Patient Participation in OI Research”. Investigators were part of the Brittle Bone Disease Consortium (BBDC), a multicenter research program devoted to the study of OI, and their focus was on patient-reported outcomes (PRO). Results Participants noted that while fractures and brittle bones are the most common feature of OI, a number of body systems are under-studied in this disorder. They particularly emphasized breathing, hearing, and the effects of aging as primary concerns that researchers and physicians may not fully understand or address. Other areas included pain, gastrointestinal problems, mental health, nutrition, menopause/pregnancy, and basilar invagination. Participants also emphasized that they must be informed of study results. They underscored that outcome measures incorporated into future drug trials must look beyond fractures and consider the whole patient. Conclusions This work will help guide the incorporation of PROs into the next phase of the BBDC Natural History Study of OI and underscores the importance of including PROs in the study of rare diseases.
- 6 September 2018
- Published by Springer Nature in Osteoporosis International
- Vol. 30 (2) , 507-511
Open AccessIncorporating the patient perspective in the study of rare bone disease: insights from the osteogenesis imperfecta community
Summary There is limited research which examines health concerns of individuals with osteogenesis imperfecta (OI). Discussion groups with leaders of the adult OI community identified a broad range of medical priorities beyond fractures and brittle bones. Our work underscores the need to include patient-reported outcomes in rare bone disease research. Introduction Osteogenesis imperfecta (OI) is a rare genetic disorder affecting collagen protein leading to brittle bones and a number of other medical complications. To date, there is limited research which examines the life-long process of aging with this rare disease, much less the perspective of individuals with OI. Methods In order to explore and prioritize health concerns that adults with OI feel have been inadequately addressed in health care and research, investigators held discussions with leaders from the global adult OI community. The meetings were held in August 2017 at the 13th International Conference on OI in Oslo, Norway as part of the preconference seminar “Patient Participation in OI Research”. Investigators were part of the Brittle Bone Disease Consortium (BBDC), a multicenter research program devoted to the study of OI, and their focus was on patient-reported outcomes (PRO). Results Participants noted that while fractures and brittle bones are the most common feature of OI, a number of body systems are under-studied in this disorder. They particularly emphasized breathing, hearing, and the effects of aging as primary concerns that researchers and physicians may not fully understand or address. Other areas included pain, gastrointestinal problems, mental health, nutrition, menopause/pregnancy, and basilar invagination. Participants also emphasized that they must be informed of study results. They underscored that outcome measures incorporated into future drug trials must look beyond fractures and consider the whole patient. Conclusions This work will help guide the incorporation of PROs into the next phase of the BBDC Natural History Study of OI and underscores the importance of including PROs in the study of rare diseases.